<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">akusherstvo</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics, Gynecology and Reproduction</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство, Гинекология и Репродукция</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7347</issn><issn pub-type="epub">2500-3194</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2313-7347/ob.gyn.rep.2023.442</article-id><article-id custom-type="elpub" pub-id-type="custom">akusherstvo-1767</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ ОБЗОРЫ</subject></subj-group></article-categories><title-group><article-title>Regarding the prospects of using Lactobacillus-based probiotics, D-mannose and cranberry extracts in therapy of urinary tract infections</article-title><trans-title-group xml:lang="ru"><trans-title>О перспективах применения лактобактериальных пробиотиков, D-маннозы и экстрактов клюквы в терапии инфекций мочевыводящих путей</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7663-710X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Громова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gromova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Громова Ольга Алексеевна – д.м.н., профессор, ведущий научный сотрудник</p><p>119333 Москва, ул. Вавилова, д. 44, корп. 2</p></bio><bio xml:lang="en"><p>Olga A. Gromova – MD, Dr Sci Med, Professor, Leading Researcher</p><p>44 bldg. 2, Vavilova Str., Moscow 119333</p></bio><email xlink:type="simple">unesco.gromova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2659-7998</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Торшин</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Torshin</surname><given-names>I. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Торшин Иван Юрьевич – к.ф-м.н., к.х.н., старший научный сотрудник </p><p>Scopus Author ID: 7003300274. Author ID: 54104WOS ID: C-7683-2018</p><p>119333 Москва, ул. Вавилова, д. 44, корп. 2</p></bio><bio xml:lang="en"><p>Ivan Yu. Torshin – PhD in Applied Mathematics, PhD in Chemistry, Senior Researcher</p><p>Scopus Author ID: 7003300274 Author ID: 54104WOS ID: C-7683-2018</p><p>44 bldg. 2, Vavilova Str., Moscow 119333</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГУ «Федеральный исследовательский центр "Информатика и управление" Российской академии наук»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Research Center "Computer Science and Control", Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>06</day><month>09</month><year>2023</year></pub-date><volume>17</volume><issue>4</issue><fpage>485</fpage><lpage>499</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Gromova O.A., Torshin I.Y., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Громова О.А., Торшин И.Ю.</copyright-holder><copyright-holder xml:lang="en">Gromova O.A., Torshin I.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.gynecology.su/jour/article/view/1767">https://www.gynecology.su/jour/article/view/1767</self-uri><abstract><p>Antibiotics are most often used to combat urinary tract infections (UTIs). Taking into account the side effects related to antibiotic therapy, existing antibiotic-resistant strains of uropathogens, as well as the low effectiveness of the vast majority of antibiotics against bacterial agglomerations (biofilms), a search for alternative approaches to treat UTIs is highly relevant. One of the important in such search is presented by use of nutraceuticals – D-mannose (prevents interaction between pathogenic E. coli strains and the urothelium, destroys bacterial biofilms), Lactobacilli (prevents formation of bacterial pathogen biofilms, normalizes human microbiome, alleviates inflammation) and standardized cranberry extracts (inhibits uropathogen adhesion, exerts anti-inflammatory action). The results from basic and clinical studies suggest not only about high safety of such pharmaconutraceutical support of UTIs therapy, but also the effectiveness of separate and combined use of such nutraceuticals comparable to that of antibiotics, especially in treatment of uncomplicated UTIs forms</p></abstract><trans-abstract xml:lang="ru"><p>Для борьбы с инфекциями мочевыводящих путей (ИМП) чаще всего используются антибиотики. Принимая во внимание побочные эффекты антибиотикотерапии, существование штаммов уропатогенов, резистентных к антибиотикам, и низкую эффективность подавляющего большинства антибиотиков по отношению к бактериальным агломерациям (биоплёнкам), весьма актуален поиск альтернативных подходов к терапии ИМП. Одним из важных направлений этого поиска является использование нутрицевтиков – D-маннозы (предотвращает взаимодействие патогенных штаммов E. coli с уротелием, разрушает биоплёнки), лактобактерий (препятствуют образованию биоплёнок бактериальных патогенов, нормализуют микробиом человека, снижают воспаление) и стандартизированных экстрактов клюквы (нарушают адгезию уропатогенов, оказывают противовоспалительное действие). Результаты фундаментальных и клинических исследований указывают не только на высокую безопасность такого фармаконутрицевтического сопровождения терапии ИМП, но и на эффективность раздельного и сочетанного приёма этих нутрицевтиков, сопоставимую с эффективностью антибиотиков, особенно при лечении неосложнённых форм ИМП.</p><p> </p></trans-abstract><kwd-group xml:lang="ru"><kwd>инфекции мочевыводящих путей</kwd><kwd>ИМП</kwd><kwd>лактобациллы LC-11</kwd><kwd>D-манноза</kwd><kwd>стандартизированный экстракт клюквы</kwd><kwd>Lactoflorene® Цист</kwd><kwd>систематический анализ данных</kwd></kwd-group><kwd-group xml:lang="en"><kwd>urinary tract infections</kwd><kwd>UTIs</kwd><kwd>Lactobacillus LC-11</kwd><kwd>D-mannose</kwd><kwd>standardized cranberry extract</kwd><kwd>Lactoflorene® Cist</kwd><kwd>systematic data analysis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Getaneh T., Negesse A., Dessie G. et al. Prevalence of urinary tract infection and its associated factors among pregnant women in Ethiopia: a systematic review and meta-analysis. Biomed Res Int. 2021;2021:6551526. https://doi.org/10.1155/2021/6551526.</mixed-citation><mixed-citation xml:lang="en">Getaneh T., Negesse A., Dessie G. et al. Prevalence of urinary tract infection and its associated factors among pregnant women in Ethiopia: a systematic review and meta-analysis. Biomed Res Int. 2021;2021:6551526. https://doi.org/10.1155/2021/6551526.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Chelkeba L., Fanta K., Mulugeta T., Melaku T. Bacterial profile and antimicrobial resistance patterns of common bacteria among pregnant women with bacteriuria in Ethiopia: a systematic review and metaanalysis. Arch Gynecol Obstet. 2022;306(3):663–86. https://doi.org/10.1007/s00404-021-06365-4.</mixed-citation><mixed-citation xml:lang="en">Chelkeba L., Fanta K., Mulugeta T., Melaku T. Bacterial profile and antimicrobial resistance patterns of common bacteria among pregnant women with bacteriuria in Ethiopia: a systematic review and metaanalysis. Arch Gynecol Obstet. 2022;306(3):663–86. https://doi.org/10.1007/s00404-021-06365-4.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">González-Garay A., Velasco-Hidalgo L., Ochoa-Hein E., Rivera-Luna R. Efficacy and safety of quinolones for the treatment of uncomplicated urinary tract infections in women: a network meta-analysis. Int Urogynecol J. 2021;32(1):3–15. https://doi.org/10.1007/s00192-020-04255-y.</mixed-citation><mixed-citation xml:lang="en">González-Garay A., Velasco-Hidalgo L., Ochoa-Hein E., Rivera-Luna R. Efficacy and safety of quinolones for the treatment of uncomplicated urinary tract infections in women: a network meta-analysis. Int Urogynecol J. 2021;32(1):3–15. https://doi.org/10.1007/s00192-020-04255-y.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lenger S.M., Bradley M.S., Thomas D.A. et al. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;223(2):265.e1–265.e13. https://doi.org/10.1016/j.ajog.2020.05.048.</mixed-citation><mixed-citation xml:lang="en">Lenger S.M., Bradley M.S., Thomas D.A. et al. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;223(2):265.e1–265.e13. https://doi.org/10.1016/j.ajog.2020.05.048.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Зайцев А.В., Перепанова Т.С., Гвоздев М.Ю., Арефьева О.А. Инфекции мочевыводящих путей: методические рекомендации № 57. М.: АБВ-пресс, 2018. 26 с.</mixed-citation><mixed-citation xml:lang="en">Zaitsev A.V., Perepanova T.S., Gvozdev M.Yu., Arefieva O.A. Urinary tract infections: guidelines No. 57. [Infekcii mochevyvodyashchih putej: metodicheskie rekomendacii № 57]. Moscow: ABV-press, 2018. 26 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Delcaru C., Alexandru I., Podgoreanu P. et al. Microbial biofilms in urinary tract infections and prostatitis: etiology, pathogenicity, and combating strategies. Pathogens. 2016;5(4):65. https://doi.org/10.3390/pathogens5040065.</mixed-citation><mixed-citation xml:lang="en">Delcaru C., Alexandru I., Podgoreanu P. et al. Microbial biofilms in urinary tract infections and prostatitis: etiology, pathogenicity, and combating strategies. Pathogens. 2016;5(4):65. https://doi.org/10.3390/pathogens5040065.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">McMillan A., Dell M., Zellar M.P. et al. Disruption of urogenital biofilms by lactobacilli. Colloids Surf B Biointerfaces. 2011;86(1):58–64. https://doi.org/10.1016/j.colsurfb.2011.03.016.</mixed-citation><mixed-citation xml:lang="en">McMillan A., Dell M., Zellar M.P. et al. Disruption of urogenital biofilms by lactobacilli. Colloids Surf B Biointerfaces. 2011;86(1):58–64. https://doi.org/10.1016/j.colsurfb.2011.03.016.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Soto M. Importance of biofilms in urinary tract infections: new therapeutic approaches. Adv Biol. 2014;5:1–13. https://doi.org/10.1155/2014/543974.</mixed-citation><mixed-citation xml:lang="en">Soto M. Importance of biofilms in urinary tract infections: new therapeutic approaches. Adv Biol. 2014;5:1–13. https://doi.org/10.1155/2014/543974.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Hall-Stoodley L., Costerton J.W., Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2(2):95–108. https://doi.org/10.1038/nrmicro821.</mixed-citation><mixed-citation xml:lang="en">Hall-Stoodley L., Costerton J.W., Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2(2):95–108. https://doi.org/10.1038/nrmicro821.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Parsek M.R., Singh P.K. Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol. 2003;57:677–701. https://doi.org/10.1146/annurev.micro.57.030502.090720.</mixed-citation><mixed-citation xml:lang="en">Parsek M.R., Singh P.K. Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol. 2003;57:677–701. https://doi.org/10.1146/annurev.micro.57.030502.090720.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Imamura Y., Chandra J., Mukherjee P.K. et al. Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions. Antimicrob Agents Chemother. 2008;52(1):171–82. https://doi.org/10.1128/AAC.00387-07.</mixed-citation><mixed-citation xml:lang="en">Imamura Y., Chandra J., Mukherjee P.K. et al. Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions. Antimicrob Agents Chemother. 2008;52(1):171–82. https://doi.org/10.1128/AAC.00387-07.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Patterson J.L., Girerd P.H., Karjane N.W., Jefferson K.K. Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid. Am J Obstet Gynecol. 2007;197(2):170.e1–7. https://doi.org/10.1016/j.ajog.2007.02.027.</mixed-citation><mixed-citation xml:lang="en">Patterson J.L., Girerd P.H., Karjane N.W., Jefferson K.K. Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid. Am J Obstet Gynecol. 2007;197(2):170.e1–7. https://doi.org/10.1016/j.ajog.2007.02.027.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Patterson J.L., Stull-Lane A., Girerd P.H., Jefferson K.K. Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosisassociated anaerobes. Microbiology (Reading). 2010;156(Pt 2):392–9. https://doi.org/10.1099/mic.0.034280-0.</mixed-citation><mixed-citation xml:lang="en">Patterson J.L., Stull-Lane A., Girerd P.H., Jefferson K.K. Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosisassociated anaerobes. Microbiology (Reading). 2010;156(Pt 2):392–9. https://doi.org/10.1099/mic.0.034280-0.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Swidsinski A., Mendling W., Loening-Baucke V. et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol. 2008;198(1):97.e1–6. https://doi.org/10.1016/j.ajog.2007.06.039.</mixed-citation><mixed-citation xml:lang="en">Swidsinski A., Mendling W., Loening-Baucke V. et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol. 2008;198(1):97.e1–6. https://doi.org/10.1016/j.ajog.2007.06.039.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Rogers A.H. Molecular oral microbiology. Caister Academic Press, 2008. 292 p. https://doi.org/10.21775/9781912530069.</mixed-citation><mixed-citation xml:lang="en">Rogers A.H. Molecular oral microbiology. Caister Academic Press, 2008. 292 p. https://doi.org/10.21775/9781912530069.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Gondil V.S., Subhadra B. Biofilms and their role on diseases. BMC Microbiol. 2023;23(1):203. https://doi.org/10.1186/s12866-023-02954-2.</mixed-citation><mixed-citation xml:lang="en">Gondil V.S., Subhadra B. Biofilms and their role on diseases. BMC Microbiol. 2023;23(1):203. https://doi.org/10.1186/s12866-023-02954-2.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Garg S.S., Dubey R., Sharma S. et al. Biological macromolecules-based nanoformulation in improving wound healing and bacterial biofilmassociated infection: a review. Int J Biol Macromol. 2023;247:125636. https://doi.org/10.1016/j.ijbiomac.2023.125636.</mixed-citation><mixed-citation xml:lang="en">Garg S.S., Dubey R., Sharma S. et al. Biological macromolecules-based nanoformulation in improving wound healing and bacterial biofilmassociated infection: a review. Int J Biol Macromol. 2023;247:125636. https://doi.org/10.1016/j.ijbiomac.2023.125636.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю. Микронутриенты и репродуктивное здоровье: руководство. M.: ГЭОТАР-Медиа, 2019. 672 с.</mixed-citation><mixed-citation xml:lang="en">Gromova O.A., Torshin I.Yu. Micronutrients and reproductive health: a guide. [Mikronutrienty i reproduktivnoe zdorov'e: rukovodstvo]. Moscow: GEOTAR-Media, 2019. 672 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Tabasi M., Asadi Karam M.R., Habibi M. et al. Phenotypic assays to determine virulence factors of uropathogenic Escherichia coli (UPEC) isolates and their correlation with antibiotic resistance pattern. Osong Public Health Res Perspect. 2015;6(4):261–8. https://doi.org/10.1016/j.phrp.2015.08.002.</mixed-citation><mixed-citation xml:lang="en">Tabasi M., Asadi Karam M.R., Habibi M. et al. Phenotypic assays to determine virulence factors of uropathogenic Escherichia coli (UPEC) isolates and their correlation with antibiotic resistance pattern. Osong Public Health Res Perspect. 2015;6(4):261–8. https://doi.org/10.1016/j.phrp.2015.08.002.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Komesu Y.M., Dinwiddie D.L., Richter H.E. et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Pelvic Floor Disorders Network. Defining the relationship between vaginal and urinary microbiomes. Am J Obstet Gynecol. 2020;222(2):154.e1–154.e10. https://doi.org/10.1016/j.ajog.2019.08.011.</mixed-citation><mixed-citation xml:lang="en">Komesu Y.M., Dinwiddie D.L., Richter H.E. et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Pelvic Floor Disorders Network. Defining the relationship between vaginal and urinary microbiomes. Am J Obstet Gynecol. 2020;222(2):154.e1–154.e10. https://doi.org/10.1016/j.ajog.2019.08.011.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Murina F., Graziottin A., Felice R., Di Francesco S. Coital pain in the elderly: could a low dose estriol gel thrill the vulvar vestibule? Eur J Obstet Gynecol Reprod Biol. 2016;207:121–4. https://doi.org/10.1016/j.ejogrb.2016.10.016.</mixed-citation><mixed-citation xml:lang="en">Murina F., Graziottin A., Felice R., Di Francesco S. Coital pain in the elderly: could a low dose estriol gel thrill the vulvar vestibule? Eur J Obstet Gynecol Reprod Biol. 2016;207:121–4. https://doi.org/10.1016/j.ejogrb.2016.10.016.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Shim Y.H., Lee S.J., Lee J.W. Antimicrobial activity of lactobacillus strains against uropathogens. Pediatr Int. 2016;58(10):1009–13. https://doi.org/10.1111/ped.12949.</mixed-citation><mixed-citation xml:lang="en">Shim Y.H., Lee S.J., Lee J.W. Antimicrobial activity of lactobacillus strains against uropathogens. Pediatr Int. 2016;58(10):1009–13. https://doi.org/10.1111/ped.12949.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Schwendicke F., Korte F., Dörfer C.E. et al. Inhibition of Streptococcus mutans growth and biofilm formation by probiotics in vitro. Caries Res. 2017;51(2):87–95. https://doi.org/10.1159/000452960.</mixed-citation><mixed-citation xml:lang="en">Schwendicke F., Korte F., Dörfer C.E. et al. Inhibition of Streptococcus mutans growth and biofilm formation by probiotics in vitro. Caries Res. 2017;51(2):87–95. https://doi.org/10.1159/000452960.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Gomes A.C., Hoffmann C., Mota J.F. Gut microbiota is associated with adiposity markers and probiotics may impact specific genera. Eur J Nutr. 2020;59(4):1751–62. https://doi.org/10.1007/s00394-019-02034-0.</mixed-citation><mixed-citation xml:lang="en">Gomes A.C., Hoffmann C., Mota J.F. Gut microbiota is associated with adiposity markers and probiotics may impact specific genera. Eur J Nutr. 2020;59(4):1751–62. https://doi.org/10.1007/s00394-019-02034-0.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Cannarella L.A.T., Mari N.L., Alcântara C.C. et al. Mixture of probiotics reduces inflammatory biomarkers and improves the oxidative/nitrosative profile in people with rheumatoid arthritis. Nutrition. 2021;89:111282. https://doi.org/10.1016/j.nut.2021.111282.</mixed-citation><mixed-citation xml:lang="en">Cannarella L.A.T., Mari N.L., Alcântara C.C. et al. Mixture of probiotics reduces inflammatory biomarkers and improves the oxidative/nitrosative profile in people with rheumatoid arthritis. Nutrition. 2021;89:111282. https://doi.org/10.1016/j.nut.2021.111282.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю., Тетруашвили Н.К. Систематический анализ исследований по D-маннозе и перспективы ее применения при рецидивирующих инфекциях мочеполовых путей у женщин репродуктивного возраста. Акушерство, Гинекология и Репродукция. 2019;13(2):119–31. https://doi.org/10.17749/2313-7347.2019.13.2.119-131.</mixed-citation><mixed-citation xml:lang="en">Gromova O.A., Torshin I.Yu., Tetruashvili N.K. Systematic analysis of research on D-mannose and the prospects for its use in recurrent infections of the urinary tract in women of reproductive age. [Sistematicheskij analiz issledovanij po D-mannoze i perspektivy ee primeneniya pri recidiviruyushchih infekciyah mochepolovyh putej u zhenshchin reproduktivnogo vozrasta]. Obstetrics, Gynecology and Reproduction. 2019;13(2):119–31. (In Russ.). https://doi.org/10.17749/2313-7347.2019.13.2.119-131.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И.Ю., Аполихина И.А., Громов А.Н., Громова О.А. Свойства D-маннозы: противовоспалительный и противоопухолевый эффекты. Экспериментальная и клиническая урология. 2020;(2):164–70. https://doi.org/10.29188/2222-8543-2020-12-2-164-170.</mixed-citation><mixed-citation xml:lang="en">Torshin I.Yu., Apolikhina I.А., Gromov A.N., Gromova O.A. Concerning the properties of D-mannose: anti-inflammatory and antitumor effects. [Svojstva D-mannozy: protivovospalitel'nyj i protivoopuholevyj effekty]. Eksperimental'naya i klinicheskaya urologiya. 2020;(2):164–70. (In Russ.). https://doi.org/10.29188/2222-8543-2020-12-2-164-170.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И.Ю., Галустян А.Н., Иванова М.И. и др. Хемомикробиомный анализ синергизма D-маннозы и D-фруктозы в сравнении с другими метабиотиками. Эффективная фармакотерапия. 2020;16(20):22–31. https://doi.org/10.33978/2307-3586-2020-16-20-22-31.</mixed-citation><mixed-citation xml:lang="en">Torshin I.Yu., Galustyan A.N., Ivanova M.I. et al. Chemomicrobiome analysis of synergism of D-mannose and D-fructose in comparison with other metabiotics. [Hemomikrobiomnyj analiz sinergizma D-mannozyi D-fruktozy v sravnenii s drugimi metabiotikami]. Effektivnaya farmakoterapiya. 2020;16(20):22–31. (In Russ.). https://doi.org/10.33978/2307-3586-2020-16-20-22-31.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Eden C.S., Hagberg L., Hanson L.A. et al. Adhesion of Escherichia coli in urinary tract infection. Ciba Found Symp. 1981;80:161–87. https://doi.org/10.1002/9780470720639.ch11.</mixed-citation><mixed-citation xml:lang="en">Eden C.S., Hagberg L., Hanson L.A. et al. Adhesion of Escherichia coli in urinary tract infection. Ciba Found Symp. 1981;80:161–87. https://doi.org/10.1002/9780470720639.ch11.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Schaeffer A.J., Chmiel J.S., Duncan J.L., Falkowski W.S. Mannosesensitive adherence of Escherichia coli to epithelial cells from women with recurrent urinary tract infections. J Urol. 1984;131(5):906–10. https://doi.org/10.1016/s0022-5347(17)50706-5.</mixed-citation><mixed-citation xml:lang="en">Schaeffer A.J., Chmiel J.S., Duncan J.L., Falkowski W.S. Mannosesensitive adherence of Escherichia coli to epithelial cells from women with recurrent urinary tract infections. J Urol. 1984;131(5):906–10. https://doi.org/10.1016/s0022-5347(17)50706-5.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Agata N., Ohta M., Miyazawa H. et al. Serological response to P-fimbriae of Escherichia coli in patients with urinary tract infections. Eur J Clin Microbiol Infect Dis. 1989;8(2):156–9. https://doi.org/10.1007/BF01963903.</mixed-citation><mixed-citation xml:lang="en">Agata N., Ohta M., Miyazawa H. et al. Serological response to P-fimbriae of Escherichia coli in patients with urinary tract infections. Eur J Clin Microbiol Infect Dis. 1989;8(2):156–9. https://doi.org/10.1007/BF01963903.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Nowicki B., Svanborg-Eden C., Hull R., Hull S. Molecular analysis and epidemiology of the Dr hemagglutinin of uropathogenic Escherichia coli. Infect Immun. 1989;57(2):446–51. https://doi.org/10.1128/iai.57.2.446-451.1989.</mixed-citation><mixed-citation xml:lang="en">Nowicki B., Svanborg-Eden C., Hull R., Hull S. Molecular analysis and epidemiology of the Dr hemagglutinin of uropathogenic Escherichia coli. Infect Immun. 1989;57(2):446–51. https://doi.org/10.1128/iai.57.2.446-451.1989.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Cordeiro M.A., Werle C.H., Milanez G.P., Yano T. Curli fimbria: an Escherichia coli adhesin associated with human cystitis. Braz J Microbiol. 2016;47(2):414–6. https://doi.org/10.1016/j.bjm.2016.01.024.</mixed-citation><mixed-citation xml:lang="en">Cordeiro M.A., Werle C.H., Milanez G.P., Yano T. Curli fimbria: an Escherichia coli adhesin associated with human cystitis. Braz J Microbiol. 2016;47(2):414–6. https://doi.org/10.1016/j.bjm.2016.01.024.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Pani A., Valeria L., Dugnani S. et al. Pharmacodynamics of D-mannose in the prevention of recurrent urinary infections. J Chemother. 2022;34(7):459–64. https://doi.org/10.1080/1120009X.2022.2061184.</mixed-citation><mixed-citation xml:lang="en">Pani A., Valeria L., Dugnani S. et al. Pharmacodynamics of D-mannose in the prevention of recurrent urinary infections. J Chemother. 2022;34(7):459–64. https://doi.org/10.1080/1120009X.2022.2061184.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Toyota S., Fukushi Y., Katoh S. et al. Anti-bacterial defense mechanism of the urinary bladder. Role of mannose in urine. Nihon Hinyokika Gakkai Zasshi. 1989;80(12):1816–23. (In Japanese). https://doi.org/10.5980/jpnjurol1989.80.1816.</mixed-citation><mixed-citation xml:lang="en">Toyota S., Fukushi Y., Katoh S. et al. Anti-bacterial defense mechanism of the urinary bladder. Role of mannose in urine. Nihon Hinyokika Gakkai Zasshi. 1989;80(12):1816–23. (In Japanese). https://doi.org/10.5980/jpnjurol1989.80.1816.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">De Nunzio C., Bartoletti R., Tubaro A. et al. Role of D-mannose in the prevention of recurrent uncomplicated cystitis: state of the art and future perspectives. Antibiotics. 2021;10(4):373. https://doi.org/10.3390/antibiotics10040373.</mixed-citation><mixed-citation xml:lang="en">De Nunzio C., Bartoletti R., Tubaro A. et al. Role of D-mannose in the prevention of recurrent uncomplicated cystitis: state of the art and future perspectives. Antibiotics. 2021;10(4):373. https://doi.org/10.3390/antibiotics10040373.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И.Ю., Громова О.А. Под ред. А.Г. Чучалина А.Г. Микронутриенты против коронавирусов. Вчера, сегодня, завтра. M.: ГЭОТАРМедиа, 2023. 448 с.</mixed-citation><mixed-citation xml:lang="en">Torshin I.Yu., Gromova O.A. Ed. A.G. Chuchalin. Micronutrients against coronaviruses. Yesterday, today, tomorrow. [Mikronutrienty protiv koronavirusov. Vchera, segodnya, zavtra]. Moscow: GEOTAR-Media, 2023. 448 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Берников А.Н., Куприянов Ю.А., Строганов Р.В. и др. Симптомы нижних мочевыводящих путей и COVID-19. Урология. 2021;(5):78–83. https://doi.org/10.18565/urology.2021.5.78-83.</mixed-citation><mixed-citation xml:lang="en">Bernikov A.N., Kupriyanov Yu.A., Stroganov R.V. Lower urinary tract symptoms and COVID-19. [Simptomy nizhnih mochevyvodyashchih putej i COVID-19]. Urologiya. 2021;(5):78–83. (In Russ.). https://doi.org/10.18565/urology.2021.5.78-83.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Mitrani-Gold F.S., Raychaudhuri A., Rao S. Systematic review and metaanalysis to estimate the antibacterial treatment effect of nitrofurantoin for a non-inferiority trial in uncomplicated urinary tract infection. J Glob Antimicrob Resist. 2020;22:68–77. https://doi.org/10.1016/j.jgar.2020.01.027.</mixed-citation><mixed-citation xml:lang="en">Mitrani-Gold F.S., Raychaudhuri A., Rao S. Systematic review and metaanalysis to estimate the antibacterial treatment effect of nitrofurantoin for a non-inferiority trial in uncomplicated urinary tract infection. J Glob Antimicrob Resist. 2020;22:68–77. https://doi.org/10.1016/j.jgar.2020.01.027.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Agresti A., Caffo B. Simple and effective confidence Intervals for proportions and differences of proportions result from adding two successes and two failures. Am Stat. 2000;54(4):280–8.</mixed-citation><mixed-citation xml:lang="en">Agresti A., Caffo B. Simple and effective confidence Intervals for proportions and differences of proportions result from adding two successes and two failures. Am Stat. 2000;54(4):280–8.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Falagas M.E., Vouloumanou E.K., Togias A.G. et al. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2010;65(9):1862–77. https://doi.org/10.1093/jac/dkq237.</mixed-citation><mixed-citation xml:lang="en">Falagas M.E., Vouloumanou E.K., Togias A.G. et al. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2010;65(9):1862–77. https://doi.org/10.1093/jac/dkq237.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Alfaresi M., Hassan K., Alnjadat R.M.H. Single-dose Fosfomycin trometamol versus other antimicrobial regimens for treatment of uncomplicated lower urinary tract infection: a systematic review and meta-analysis. Open Microbiol J. 2019;13(1):193–9. https://doi.org/10.2174/1874285801913010193.</mixed-citation><mixed-citation xml:lang="en">Alfaresi M., Hassan K., Alnjadat R.M.H. Single-dose Fosfomycin trometamol versus other antimicrobial regimens for treatment of uncomplicated lower urinary tract infection: a systematic review and meta-analysis. Open Microbiol J. 2019;13(1):193–9. https://doi.org/10.2174/1874285801913010193.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Kranjcec B., Papes D., Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014;32(1):79–84. https://doi.org/10.1007/s00345-013-1091-6.</mixed-citation><mixed-citation xml:lang="en">Kranjcec B., Papes D., Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014;32(1):79–84. https://doi.org/10.1007/s00345-013-1091-6.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Wagenlehner F., Lorenz H., Ewald O., Gerke P. Why D-mannose may be as efficient as antibiotics in the treatment of acute uncomplicated lower urinary tract infections-preliminary considerations and conclusions from a non-interventional study. Antibiotics. 2022;11(3):314. https://doi.org/10.3390/antibiotics11030314.</mixed-citation><mixed-citation xml:lang="en">Wagenlehner F., Lorenz H., Ewald O., Gerke P. Why D-mannose may be as efficient as antibiotics in the treatment of acute uncomplicated lower urinary tract infections-preliminary considerations and conclusions from a non-interventional study. Antibiotics. 2022;11(3):314. https://doi.org/10.3390/antibiotics11030314.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Kaur R., Kaur R. Symptoms, risk factors, diagnosis and treatment of urinary tract infections. Postgrad Med J. 2021;97(1154):803–12. https://doi.org/10.1136/postgradmedj-2020-139090.</mixed-citation><mixed-citation xml:lang="en">Kaur R., Kaur R. Symptoms, risk factors, diagnosis and treatment of urinary tract infections. Postgrad Med J. 2021;97(1154):803–12. https://doi.org/10.1136/postgradmedj-2020-139090.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Chiu K., Zhang F., Sutcliffe S. et al. Recurrent urinary tract infection incidence rates decrease in women with cystitis cystica after treatment with D-mannose: a cohort study. Female Pelvic Med Reconstr Surg. 2022;28(3):e62–e65. https://doi.org/10.1097/SPV.0000000000001144.</mixed-citation><mixed-citation xml:lang="en">Chiu K., Zhang F., Sutcliffe S. et al. Recurrent urinary tract infection incidence rates decrease in women with cystitis cystica after treatment with D-mannose: a cohort study. Female Pelvic Med Reconstr Surg. 2022;28(3):e62–e65. https://doi.org/10.1097/SPV.0000000000001144.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Harmidy K., Tufenkji N., Gruenheid S. Perturbation of host cell cytoskeleton by cranberry proanthocyanidins and their effect on enteric infections. PLoS One. 2011;6(11):e27267. https://doi.org/10.1371/journal.pone.0027267.</mixed-citation><mixed-citation xml:lang="en">Harmidy K., Tufenkji N., Gruenheid S. Perturbation of host cell cytoskeleton by cranberry proanthocyanidins and their effect on enteric infections. PLoS One. 2011;6(11):e27267. https://doi.org/10.1371/journal.pone.0027267.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Howell A.B., Reed J.D., Krueger C.G. et al. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry. 2005;66(18):2281–91. https://doi.org/10.1016/j.phytochem.2005.05.022.</mixed-citation><mixed-citation xml:lang="en">Howell A.B., Reed J.D., Krueger C.G. et al. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry. 2005;66(18):2281–91. https://doi.org/10.1016/j.phytochem.2005.05.022.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Parazzini F., Ricci E., Fedele F. et al. Systematic review of the effect of D-mannose with or without other drugs in the treatment of symptoms of urinary tract infections/cystitis (Review). Biomed Rep. 2022;17(2):69. https://doi.org/10.3892/br.2022.1552.</mixed-citation><mixed-citation xml:lang="en">Parazzini F., Ricci E., Fedele F. et al. Systematic review of the effect of D-mannose with or without other drugs in the treatment of symptoms of urinary tract infections/cystitis (Review). Biomed Rep. 2022;17(2):69. https://doi.org/10.3892/br.2022.1552.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Fu Z., Liska D., Talan D., Chung M. Cranberry reduces the risk of urinary tract infection recurrence in otherwise healthy women: a systematic review and meta-analysis. J Nutr. 2017;147(12):2282–8. https://doi.org/10.3945/jn.117.254961.</mixed-citation><mixed-citation xml:lang="en">Fu Z., Liska D., Talan D., Chung M. Cranberry reduces the risk of urinary tract infection recurrence in otherwise healthy women: a systematic review and meta-analysis. J Nutr. 2017;147(12):2282–8. https://doi.org/10.3945/jn.117.254961.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">DE Leo V., Cappelli V., Massaro M.G. et al. Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina® and D-mannose in recurrent urinary infections in perimenopausal women. Minerva Ginecol. 2017;69(4):336–41. (In Italian). https://doi.org/10.23736/S0026-4784.17.04074-6.</mixed-citation><mixed-citation xml:lang="en">DE Leo V., Cappelli V., Massaro M.G. et al. Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina® and D-mannose in recurrent urinary infections in perimenopausal women. Minerva Ginecol. 2017;69(4):336–41. (In Italian). https://doi.org/10.23736/S0026-4784.17.04074-6.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Xia J.Y., Yang C., Xu D.F. et al. Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: a systematic review and meta-analysis with trial sequential analysis. PLoS One. 2021;16(9):e0256992. https://doi.org/10.1371/journal.pone.0256992.</mixed-citation><mixed-citation xml:lang="en">Xia J.Y., Yang C., Xu D.F. et al. Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: a systematic review and meta-analysis with trial sequential analysis. PLoS One. 2021;16(9):e0256992. https://doi.org/10.1371/journal.pone.0256992.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Raditic D.M. Complementary and integrative therapies for lower urinary tract diseases. Vet Clin North Am Small Anim Pract. 2015;45(4):857–78. https://doi.org/10.1016/j.cvsm.2015.02.009.</mixed-citation><mixed-citation xml:lang="en">Raditic D.M. Complementary and integrative therapies for lower urinary tract diseases. Vet Clin North Am Small Anim Pract. 2015;45(4):857–78. https://doi.org/10.1016/j.cvsm.2015.02.009.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Vicariotto F. Effectiveness of an association of a cranberry dry extract, D-mannose, and the two microorganisms Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09 in women affected by cystitis: a pilot study. J Clin Gastroenterol. 2014;48 Suppl 1:S96–101. https://doi.org/10.1097/MCG.0000000000000224.</mixed-citation><mixed-citation xml:lang="en">Vicariotto F. Effectiveness of an association of a cranberry dry extract, D-mannose, and the two microorganisms Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09 in women affected by cystitis: a pilot study. J Clin Gastroenterol. 2014;48 Suppl 1:S96–101. https://doi.org/10.1097/MCG.0000000000000224.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Murina F., Vicariotto F., Lubrano C. Efficacy of an orally administered combination of Lactobacillus paracasei LC11, cranberry and D-mannose for the prevention of uncomplicated, recurrent urinary tract infections in women. Urologia. 2021;88(1):64–68. https://doi.org/10.1177/0391560320957483.</mixed-citation><mixed-citation xml:lang="en">Murina F., Vicariotto F., Lubrano C. Efficacy of an orally administered combination of Lactobacillus paracasei LC11, cranberry and D-mannose for the prevention of uncomplicated, recurrent urinary tract infections in women. Urologia. 2021;88(1):64–68. https://doi.org/10.1177/0391560320957483.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
